The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...

Together with Habener and others, she proved this theory through lab experiments and human trials, identifying its ...

The project is part of Novo Nordisk’s digital therapeutics strategy and will first focus on creating a “virtual innovation lab” between Novo and UVA’s Center for Diabetes Technology.

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill.

Last October Novo Nordisk announced that it had shelved plans ... Professor Robert Langer and his biotech and materials science lab at the Massachusetts Institute of Technology (MIT).

The Northeast Microelectronics Coalition Hub announced on Wednesday that it had been awarded $37.8 million in federal ...

It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so ...